Market cap
₹162 Cr
Recently Viewed
Clear AllNSE: NATCAPSUQ | BSE: 524654
₹156.22
₹0.33
(0.21%)
As on 29-Apr-2026IST
Market cap
₹162 Cr
Revenue (TTM)
₹174 Cr
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹-19 Cr
ROE
0.3 %
ROCE
2.9 %
Industry P/E
30.6
EV/EBITDA
96.8
Debt to Equity
0.4
Book Value
₹211.5
EPS
₹-18.5
Face value
10
Shares outstanding
10,386,154
CFO
₹60.91 Cr
EBITDA
₹136.63 Cr
Net Profit
₹54.30 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Natural Capsules
| -5.9 | 8.8 | -5.7 | -23.0 | -- | -- | -- |
|
BSE Healthcare
| 2.8 | 5.2 | 8.2 | 4.9 | 24.7 | 13.9 | 11.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Natural Capsules
|
156.2 | 162.0 | 173.7 | -19.2 | -7.8 | -8.3 | -- | 0.7 |
| 2,804.2 | 35,045.7 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.5 | 7.6 | |
| 8,369.0 | 20,952.5 | 2,177.5 | 200.9 | 11.3 | 26.5 | 104.3 | 25.2 | |
| 1,727.6 | 13,117.3 | 2,089.5 | 622.0 | 31.3 | 20.4 | 21.4 | 3.9 | |
| 1,690.2 | 10,331.2 | 1,196.4 | 149.4 | -- | 27.5 | 69.1 | 14.7 | |
| 1,316.2 | 18,223.9 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.2 | 5.0 | |
| 2,061.2 | 33,122.5 | 4,193.0 | 753.8 | 22.7 | 20.8 | 43.9 | 8.3 | |
| 4,763.0 | 21,794.9 | 2,482.3 | 853.6 | 33.7 | 18.9 | 25.5 | 5.5 | |
| 5,135.0 | 8,509.3 | 1,348.5 | 293.5 | 28.1 | 50.7 | 29 | 12.2 | |
| 1,053.5 | 9,708.1 | 4,725.6 | 528.7 | 14.9 | 20.7 | 19 | 3.3 |
No Review & Analysis are available.
Natural Capsules Limited engages in the manufacture and sale of hard gelatin and cellulose capsule shells in India and internationally. The company offers bovine spongiform encephalopathy and transmissible spongiform encephalopathy-free gelatin,... shiny gelatin, sodium lauryl sulfate-free gelatin, halal-certified gelatin, fast-release gelatin, printed gelatin/cellulose, vegetarian, and enteric capsule shells. It is also involved in formulating pharmaceutical dosage forms in capsule dosage form. Natural Capsules Limited was incorporated in 1993 and is based in Bengaluru, India. Read more
Incorporated
1993
Chairman
Tekkar Yashwanth Prabhu
Managing Director
Sunil L Mundra
Headquarters
Bengaluru, Karnataka
Website
Looking for more details about Natural Capsules Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Natural Capsules Ltd is ₹156.22 (NSE) and ₹156.00 (BSE) as of 29-Apr-2026 IST. Natural Capsules Ltd has given a return of -23% in the last 1 years.
Since, TTM earnings of Natural Capsules Ltd is negative, P/E ratio is not available.
The P/B ratio of Natural Capsules Ltd is 0.74 times as on 29-Apr-2026, a 84 discount to its peers’ median range of 4.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
308.53
|
0.82
|
|
2024
|
51.33
|
1.40
|
|
2023
|
19.76
|
2.96
|
|
2022
|
23.63
|
3.91
|
|
2021
|
8.03
|
1.08
|
The 52-week high and low of Natural Capsules Ltd are Rs 296.00 and Rs 136.36 as of 29-Apr-2026.
Natural Capsules Ltd has a market capitalisation of ₹ 162 Cr as on 29-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Natural Capsules Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.